RecruitingNCT06806579
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Studying Adult hepatocellular carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Principal Investigator
- Francesco Tovoli, MD, M.D., Ph.DIRCCS Azienda Ospedaliero-Universitaria di Bologna
- Enrollment
- 1000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2031
Study locations (24)
- Ospedali Riuniti Ancona, Via Conca, 71, 60126 Torrette AN, Torrette, AN, Italy
- I.R.C.C.S. "S. De Bellis", Via Turi, 27, 70013 Castellana Grotte BA, Castellana Grotte, BA, Italy
- AUSL Bologna Via Castiglione 15 40136 Bologna BO, Bologna, BO, Italy
- IRCCS Azienda Ospedaliero-Universitaria di Bologna (Oncology Unit), Bologna, BO 40136, Bologna, BO, Italy
- IRCCS Azienda Ospedaliero-Universitaria di Bologna (Semiotics Unit), Bologna, BO, Italy
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, BO, Italy
- Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione "Garibaldi, Piazza Santa Maria di Gesù, 5, 95123 Catania CT, Catania, CT, Italy
- Ospedali Riuniti. Viale Pinto Luigi, 1, 71122 Foggia FG., Foggia, FG, Italy
- Ospedali Riuniti. Viale Pinto Luigi, 1, 71122 Foggia FG, Foggia, FG, Italy
- AOU Careggi. Largo G. Alessandro Brambilla, 3. 50134 Firenze FI, Florence, FI, Italy
- Policlinico di Modena Via del Pozzo, 71, 41125 Modena MO, Modena, Missouri, Italy
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. via Francesco Sforza, 28 - 20122 Milano., Milan, MI, Italy
- ASST Grande Ospedale Metropolitano Niguarda, Piazza dell'Ospedale Maggiore, 3, 20162 Milano, Milan, MI, Italy
- Humanitas Research Hospital. Via Alessandro Manzoni, 56, 20089 Rozzano MI, Rozzano, MI, Italy
- Azienda Ospedaliero- Universitaria Paolo Giaccone. Via Liborio Giuffrè, 5, 90127 Palermo, Palermo, PA, Italy
- +9 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06806579 on ClinicalTrials.govOther trials for Adult hepatocellular carcinoma
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE2NCT07441369Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases CancerFudan University
- RECRUITINGPHASE2NCT07175441Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular CarcinomaRiboscience, LLC.
- RECRUITINGPHASE2NCT07560488Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular CarcinomaTianjin Medical University Cancer Institute and Hospital
- RECRUITINGPHASE2NCT07010497A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular CarcinomaAsan Medical Center
- RECRUITINGPHASE1, PHASE2NCT07291076A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Bristol-Myers Squibb
- RECRUITINGPHASE1, PHASE2NCT07500220Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCCBeijing Biotech
- RECRUITINGPHASE2NCT07413354Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular CarcinomaTongji Hospital
- RECRUITINGNANCT07365527Sonoporation and Tumor Microenvironment Response in Colorectal Liver MetastasesZealand University Hospital